A Phase I Dose-Escalation Study of Linsitinib (OSI-906), a Small-Molecule Dual Insulin-Like Growth Factor-1 Receptor/Insulin Receptor Kinase Inhibitor, in Combination with Irinotecan in Patients with Advanced Cancer.
| Image |  |
|---|---|
| Description | scientific article published on 23 August 2018 |
| Author/s |
author: Aik Choon Tan Jennifer R Diamond Todd M Pitts Stephen Leong S Gail Eckhardt Christopher H Lieu Wells A Messersmith |
| Publication date | August 23, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |